Authors: Ruiz, L Negredo, E Domingo, P Paredes, R Francia, E Balague, M Gel, S Bonjoch, A Fumaz, CR Johnston, S Romeu, J Lange, J Clotet, B

Citation: L. Ruiz et al., Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with HIV-associated lipodystrophy, J ACQ IMM D, 27(3), 2001, pp. 229-236

Authors: Tuldra, A Fumaz, CR Ferrer, MJ Paredes, R Romeu, J Ruiz, L Bayes, R Clotet, B

Citation: A. Tuldra et al., Psychological impact of structured treatment interruptions in patients with prolonged undetectable HIV-1 viral loads, AIDS, 15(14), 2001, pp. 1904-1906

Authors: Tuldra, A Fumaz, CR Ferrer, MJ Bayes, R Arno, A Balague, M Bonjoch, A Jou, A Negredo, E Paredes, R Ruiz, L Romeu, J Sirera, G Tural, C Burger, D Clotet, B

Citation: A. Tuldra et al., Prospective randomized two-arm controlled study to determine the efficacy of a specific intervention to improve long-term adherence to highly active antiretroviral therapy, J ACQ IMM D, 25(3), 2000, pp. 221-228

Authors: Negredo, E Paredes, R Bonjoch, A Tuldra, A Fumaz, CR Gel, S Garces, B Johnston, S Arno, A Balague, M Jou, A Tural, C Sirera, G Romeu, J Cruz, L Francia, E Domingo, P Arrizabalaga, J Ruiz, I Arribas, JR Ruiz, L Clotet, B

Citation: E. Negredo et al., Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up, ANTIVIR TH, 4, 1999, pp. 23-28

Authors: Tuldra, A Ferrer, MJ Fumaz, CR Bayes, R Paredes, R Burger, DM Clotet, B

Citation: A. Tuldra et al., Monitoring adherence to HIV therapy, ARCH IN MED, 159(12), 1999, pp. 1376-1377